How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping. - Wikidata - wikimedia - TriplyDB

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.

http://www.wikidata.org/entity/Q39198151

about

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine Genetic Testing for Opioid Pain Management: A Primer Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.Prevalence of clinically actionable genotypes and medication exposure of older adults in the community.Key Considerations and Methods in the Study of Gene-Environment Interactions.Prevalence and implications of cytochrome P450 substrates in Massachusetts hospital discharges.Potential utility of precision medicine for older adults with polypharmacy: a case series study.CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.History repeats itself: the family medication history and pharmacogenomics.

P2860

Q27692687-6495D7EE-01BE-492B-9831-AAE607948116 Q33736174-1BE3501A-1809-4359-8F2E-4442B326B2AE Q36219247-C00DB1C1-A7E9-4952-BF1E-69C012C96902 Q36267551-B7A64024-B0E0-4626-9328-FDED43A0FB70 Q36365500-63DADEBB-DEA8-45B2-A419-E02B5C2DCB4F Q37306211-B13A166C-E958-4B20-B92D-49FFBC83607C Q37626738-1C7F1A95-9F84-4D4B-9FFA-30FD14527798 Q38796166-70B0CC2A-F6E0-4EAD-B8E1-65750352F6D9 Q39775180-EEFC535B-CE99-46EA-A3FC-8312993864E0 Q40655628-E477E538-9E28-49A3-99B6-91100F813B47 Q47309024-7F3A84B3-8640-4223-8CA3-539AD812D9EE Q50856364-BFAA622D-BF78-4E68-99CC-5E90D972C7D0

P2860

How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.

http://www.wikidata.org/entity/Q39198151

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@en

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@nl

type

label

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@en

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@nl

prefLabel

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@en

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@nl

P1433

Q39198151-CEE0CC9A-A292-43F1-8F23-105F341CBD7A

P1476

Q39198151-06445B6C-CF66-4EAD-8ECC-40FEB5AA427F

P2093

Q39198151-738A028F-83AF-4164-9B80-879B6BBC8E7F

Q39198151-BB255FF8-996F-4EC0-8F58-22E572C13718

Q39198151-F04BEDFD-4B24-45C4-9808-D083A4A46028

P2860

Q39198151-05E8B3E9-057B-4D93-BA8F-DFC97E5438F3

Q39198151-106E4035-AC6F-4E29-82A4-2C734A0BDCF1

Q39198151-27D53585-9954-4D9B-9CCF-48028EB495C5

Q39198151-280F61D2-A472-4CB9-9630-23E5E2811182

Q39198151-2E898FB3-3864-4801-BDAA-319A36599CF3

Q39198151-31415061-70FF-47F0-B509-78DAEEFA1B30

Q39198151-43305F44-BB9A-4FD2-870D-DE4437A15078

Q39198151-43A68A17-DC8E-4441-9FCC-E77988D29BC8

Q39198151-483C649A-FAE0-4356-99D5-D19C8934F628

Q39198151-7F2FEA7F-1420-4AFD-AD18-83ABDF854D29

P304

Q39198151-62ABC815-14CD-45B0-8D12-C45355464222

P31

Q39198151-B63FF90F-5D21-4681-8F0C-05F0CB845B85

P356

Q39198151-C3A00C15-7F21-414C-9007-C06DFB37F8B0

P433

Q39198151-AD64C2E0-B755-4877-B406-CB8C1ABB215D

P478

Q39198151-7AA31521-C82F-4068-B541-9BE1AF244199

P577

Q39198151-2E029773-B089-4DB4-A2E1-C4971C4555A9

P698

Q39198151-34DF5EB1-84AD-4BC2-A4CA-F0B253B78523

P356

P1433

Pharmacogenomics

P1476

How common are drug and gene i ...... CYP2C19 and CYP2D6 genotyping.

@en

P2093

Jessica Oesterheld

http://www.w3.org/2001/XMLSchema#string

Paul Verbeurgt

http://www.w3.org/2001/XMLSchema#string

Tyler Mamiya

http://www.w3.org/2001/XMLSchema#string

P2860

Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review.

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.

Impact of genetic polymorphism on drug-drug interactions mediated by cytochromes: a general approach.

Electronic health record design and implementation for pharmacogenomics: a local perspective.

Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information.

Genetic determinants of platelet response to clopidogrel.

Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs--results of the home medication review in the AGnES-studies.

P304

655-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.14.6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24798722

http://www.w3.org/2001/XMLSchema#string